UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 27, 2022

SCVX CORP.

(Exact name of registrant as specified in its charter)

(202) 733-4719

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07 Submission of Matters to a Vote of Security Holders

On July 27, 2022, SCVX Corp., a Cayman Islands exempted company (“SCVX”) held an extraordinary general meeting of its shareholders to vote on an extension of the deadline for SCVX to complete an initial business combination. The board of directors determined not to put such proposal forth to the shareholders and this meeting was concluded without conducting any business.

Item 7.01 Regulation FD Disclosure

Also on July 27, 2022, SCVX issued a press release and announced at its Extraordinary General Meeting of Shareholders that it will redeem all of its outstanding Class A ordinary shares, as SCVX will not be able to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the “Memorandum and Articles of Association”).

There will be no redemption rights or liquidating distributions with respect to SCVX’s warrants, which will expire worthless. SCVX’s initial shareholders waived their redemption rights with respect to the outstanding Class B ordinary shares issued prior to SCVX’s initial public offering.

A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: July 27, 2022

-2-

SCVX (AMEX:SCVX)
Graphique Historique de l'Action
De Jan 2023 à Fév 2023

SCVX (AMEX:SCVX)
Graphique Historique de l'Action
De Fév 2022 à Fév 2023